Alternatives to the use of fetal bovine serum: Human platelet lysates as a serum substitute in cell culture media

Altex

Volumn 28, Issue 4, 2011, Pages 305-316

  Rauch, Caroline ^a   Feifel, Elisabeth ^a   Amann, Eva Maria ^b   Spötl, Hans Peter ^b   Schennach, Harald ^b   Pfaller, Walter ^a   Gstraunthaler, Gerhard ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

Cell culture media; Fetal bovine serum; Non animal alternatives; Platelet lysates; Serum free cell culture

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1;

ANIMAL TESTING ALTERNATIVE; ARTICLE; CATTLE; CELL CULTURE; CELL GROWTH; CELL LYSATE; CULTURE MEDIUM; FETUS; GOOD MANUFACTURING PRACTICE; HUMAN; HUMAN CELL; SERUM; STEM CELL TRANSPLANTATION; THROMBOCYTE; THROMBOCYTE ACTIVATION; TISSUE ENGINEERING;

EID: 84455209594     PISSN: 09467785     EISSN: None     Source Type: Journal    
DOI: 10.14573/altex.2011.4.305     Document Type: Article

References (80)

1. Abrams, C. S. (2005). Intracellular signaling in platelets. Curr. Opin. Hematol. 12, 401-405.
2. Anitua, E., Andia, I., Ardanza, B., et al. (2004). Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb. Haemost. 91, 4-15. (Pubitemid 38111215)
3. Atala, A. (2007). Engineering tissues, organs and cells. J. Tissue Eng. Regen. Med. 1, 83-96.
4. Balk, S. D., Levine, S. P., Young, L. L., et al. (1981). Mitogenic factors present in serum but not in plasma. Proc. Natl. Acad. Sci. USA 78, 5656-5660. (Pubitemid 12245209)
5. Balls, M., Goldberg, A. M., Fentem, J. H., et al. (1995). The three Rs: the way forward. The report and recommendations of ECVAM Workshop 11. ATLA 23, 838-866.
6. Balls, M., Coecke, S., Bowe, G., et al. (2006): The importance of Good Cell Culture Practice (GCCP). ALTEX 23, Spec. Issue, 270-273.
7. Balls, M. (2010). The principles of humane experimental technique: timeless insights and unheeded warnings. ALTEX 27, Spec. Issue, 19-23.
8. Barano, J. L. S. and Hammond, J. H. (1985). Serum-free medium enhances growth and differentiation of cultured pig granulosa cells. Endocrinol. 116, 51-58. (Pubitemid 15190447)
9. Barnes, D. and Sato, G. (1980). Methods for growth of cultured cells in serum-free medium. Anal. Biochem. 102, 255-270. (Pubitemid 10115790)
10. Bartholomew, A., Sturgeon, C., Siatskas, M., et al. (2002). Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 30, 42-48. (Pubitemid 34059216)
11. Belford, D. A., Rogers, M.-L., Regester, G. O., et al. (1995). Milk-derived growth factors as serum supplements for the growth of fibroblasts and epithelial cells. In Vitro Cell. Dev. Biol. 31, 752-760.
12. Bernardo, M. E., Avanzini, M. A., Perotti, C., et al. (2007). Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for fetal calf serum substitute. J. Cell. Physiol. 211, 121-130. (Pubitemid 46363901)
13. Bieback, K., Hecker, A., Kocaömer, A., et al. (2009). Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 27, 2331-2341.
14. Blann, A. D. and Lip, G. Y. H. (1997). Hypothesis: Is soluble P-selectin a new marker of platelet activation? Atherosclerosis 128, 135-138. (Pubitemid 27092147)
15. Brunner, D., Frank, J., Appl, H., et al. (2010). Serum-free cell culture: the serum-free media interactive online database. ALTEX 27, 53-62.
16. Burnouf, T., Tseng, Y. H., Kuo, Y. P., and Su, C. Y. (2008). Solvent/detergent treatment of platelet concentrates enhances the release of growth factors. Transfusion 48, 1090-1098. (Pubitemid 351793502)
17. Chan, R. K., Liu P., Lew, D. H., et al. (2005). Expired liquid preserved platelet releasates retain proliferative activity. J. Surg. Res. 126, 55-58. (Pubitemid 40726246)
18. Chang, L. and Karin, M. (2001). Mammalian MAP kinase signalling cascades. Nature 410, 37-40. (Pubitemid 32225829)
19. Christgau, M., Moder D., Hiller, K. A., et al. (2006). Growth factors and cytokines in autologous platelet concentrate and their correlation to periodontal regeneration outcomes. J. Clin. Periodontol. 33, 837-845. (Pubitemid 44511035)
20. Coecke, S., Balls, M., Bowe, G., et al. (2005). Guidance on Good Cell Culture Practice. A report of the second ECVAM task force on Good Cell Culture Practice. ATLA 33, 261-287. (Pubitemid 40964979)
21. Cognasse, F., Boussoulade F., Chavarin, P., et al. (2006). Release of potential immunomodulatory factors during platelet storage. Transfusion 46, 1184-1189. (Pubitemid 44139493)
22. Doucet, C., Ernou, I., Zhang, Y., et al. (2005). Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J. Cell. Physiol. 205, 228-236. (Pubitemid 41428905)
23. El Backly, R., Ulivi, V., Tonachini, L., et al. (2011). Platelet lysate induces in vitro wound healing of human keratinocytes associated with a strong proinflammatory response. Tissue Eng. A 17, 1787-1800.
24. ESAC (2008). Statement on the use of FCS and other animal-derived supplements. http://ecvam.jrc.it/index.cfm?voce=s&idvoce=27&idmm= 4&idsm=27
25. Falkner, E., Appl, H., Eder, C., et al. (2006). Serum free cell culture: The free access online database. Toxicol. In Vitro 20, 395-400. (Pubitemid 43343771)
26. +cells. Am. J. Physiol. Renal Physiol. 283, F678-F688.
27. Filipic, B., Shehata, M., Toth, S., et al. (2002). Novel serum replacement based on bovine ocular fluid: a useful tool for cultivation of different animal cells in vitro. ALTEX 19, 15-20.
28. Fletcher, K., Shah, R. R., Thomas, A., et al. (2011). Novel approaches to assessing cardiac safety - proceedings of a workshop: regulators, industry and academia discuss the future of in silico cardiac modelling to predict the proarrhythmic safety of drugs. Drug Saf. 34, 439-443.
29. Frechette, J. P., Martineau, I., and Gagnon, G. (2005). Platelet-rich plasmas: growth factor content and roles in wound healing. J. Dent. Res. 84, 434-439. (Pubitemid 43827875)
30. Gachet, C. (2000). Platelet activation by ADP: the role of ADP antagonists. Ann. Med. 32, Suppl. 1, 15-20.
31. Gospodarowicz, D. and Ill, C. R. (1980). Do plasma and serum have different abilities to promote cell growth? Proc. Natl. Acad. Sci. USA 77, 2726-2730. (Pubitemid 10057908)
32. Gruber, R., Varga, F., Fischer, M. B., and Watzek, G. (2002). Platelets stimulate proliferation of bone cells: involvement of platelet-derived growth factor, microparticles and membranes. Clin. Oral Implants Res. 13, 529-535. (Pubitemid 41713080)
33. Gstraunthaler, G. J. (1988). Epithelial cells in tissue culture (Review). Renal Physiol. Biochem. 11, 1-42.
34. Gstraunthaler, G., Holcomb, T., Feifel, E., et al. (2000). Differential expression and acid-base regulation of glutaminase mRNAs in gluconeogenic LLC-PK1-FBPase+ cells. Am. J. Physiol. Renal Physiol. 278, F227-237. (Pubitemid 30131276)
35. Gstraunthaler, G. (2003). Alternatives to the use of fetal bovine serum: serum-free cell culture. ALTEX 20, 275-281.
36. Gstraunthaler, G. (2006). Standardization in cell and tissue culture - the need for specific GLP guidelines in the cell culture laboratory (Good Cell Culture Practice - GCCP). ALTEX 23, Spec. Issue, 274-277.
37. Gstraunthaler, G. (2010). The Bologna Statement on Good Cell Culture Practice (GCCP) - 10 years later. ALTEX 27, Spec. Issue, 141-146.
38. Hartung, T., Balls, M., Bardouille, C., et al. (2002). Good Cell Culture Practice. ECVAM Good cell culture practice task force report 1. ATLA 30, 407-414.
39. Hayashi, I. and Sato, G.-H. (1976). Replacement of serum by hormones permits growth of cells in a defined medium. Nature 259, 132-134.
40. Jochems, C. E. A., van der Valk, J. B. F., Stafleu, F. R., and Baumans, V. (2002). The use of fetal bovine serum: ethical or scientific problem? ATLA 30, 219-227. (Pubitemid 34534624)
41. Johansson, L., Klinth, J., Holmqvist, O., and Ohlson, S. (2003). Platelet lysate: a replacement for fetal bovine serum in animal cell culture? Cytotechnol. 42, 67-74. (Pubitemid 38129279)
42. Kamath, S., Blann, A. D., and Lip, G. Y. H. (2001). Platelet activation: assessment and quantification. Eur. Heart J. 22, 1561-1571. (Pubitemid 32801301)
43. Kaps, C., Loch, A., Haisch, A., et al. (2002). Human platelet supernatant promotes proliferation but not differentiation of articular chondrocytes. Med. Biol. Eng. Comput. 40, 485-490. (Pubitemid 34982542)
44. Kaufman, R. M. (2009). Platelet ABO matters. Transfusion 49, 5-7.
45. King, S. M. and Reed, G. L. (2002). Development of platelet secretory granules. Sem. Cell Dev. Biol. 13, 293-302. (Pubitemid 35304515)
46. Klimanskaya, I., Chung, Y., Meisner, L., et al. (2005). Human embryonic stem cells derived without feeder cells. Lancet 365, 1636-1641. (Pubitemid 40693413)
47. Kuznetsov, S. A., Mankani, M. H., and Robey, P. G. (2000). Effect of serum on human bone marrow stromal cells: ex vivo expansion and in vivo bone formation. Transplantation 70, 1780-1787. (Pubitemid 32064834)
48. Lacoste, E., Martineau, I., and Gagnon, G. (2003). Platelet concentrates: effects of calcium and thrombin on endothelial cell proliferation and growth factor release. J. Periodontol. 74, 1498-1507. (Pubitemid 37461464)
49. Lange, C., Cakiroglu, F., Spiess, A.-N., et al. (2007). Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J. Cell. Physiol. 213, 18-26. (Pubitemid 47378788)
50. Leist, M., Bremer, S., Brundin, P., et al. (2008). The biological and ethical basis of the use of human embryonic stem cells for in vitro test systems or cell therapy. ALTEX 25, 163-190.
51. Lindl, T. and Gstraunthaler, G. (2008). Zell- und Gewebekultur. Von den Grundlagen zur Laborbank. Heidelberg: Spektrum Akademischer Verlag.
52. Maguire, P. B. and Fitzgerald, D. J. (2003). Platelet proteomics. J. Thromb. Haemost. 1, 1593-1601.
53. st century: Reflections and future directions. Environ. Mol. Mutagen. 52, 339-354.
54. Martin, M. J., Muotri, A., Gage, F., and Varki, A. (2005). Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat. Med. 11, 228-232. (Pubitemid 40321360)
55. Marx, R. E., Carlson, E. R., Eichstaedt, R. M., et al. (1998). Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 85, 638-646. (Pubitemid 128641964)
56. McDevitt, T. C. and Palecek, S. P. (2008). Innovation in the culture and derivation of pluripotent human stem cells. Curr. Opin. Biotechnol. 19, 527-533.
57. McEver, R. P. (1995). Regulation of function and expression of P-selectin. Agents Actions, Suppl. 47, 117-119.
58. Minuth, W. W., Sittinger, M., and Kloth, S. (1998). Tissue engineering: generation of differentiated artificial tissues for biomedical applications. Cell Tissue Res. 291, 1-11. (Pubitemid 28081561)
59. Ogino, Y., Ayukawa, Y., Kukita, T., and Koyano, K. (2006). The contribution of platelet-derived growth factor, transforming growth factor-beta1, and insulin-like growth factor-I in platelet-rich plasma to the proliferation of osteoblast-like cells. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 101, 724-729. (Pubitemid 43775450)
60. Park, D. H. and Eve, D. J. (2009). Regenerative medicine: advances in new methods and technologies. Med. Sci. Monit. 15, RA233-251.
61. Pazos, P., Boveri, M., Gennari, A., et al. (2004). Culturing cells without serum: Lessons learnt using molecules of plant origin. ALTEX 21, 67-72. (Pubitemid 38979273)
62. Pearson, G., Robinson, F., Beers Gibson, T., et al. (2001). Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22, 153-183. (Pubitemid 32458157)
63. Pfaller, W., Gstraunthaler, G., and Loidl, P. (1990). Morphology of the differentiation and maturation of LLC-PK1 epithelia. J. Cell. Physiol. 142, 247-254.
64. Reed, G. L., Fitzgerald, M. L., and Polgar, J. (2000). Molecular mechanisms of platelet exocytosis: insights into the "secrete"life of thrombocytes. Blood 96, 3334-3342.
65. Rendu, F. and Brohard-Bohn, B. (2001). The platelet release reaction: granules' constituents, secretion and functions. Platelets 12, 261-273. (Pubitemid 32730513)
66. Schallmoser, K., Bartmann, C., Rohde, E., et al. (2007). Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 47, 1436-1446. (Pubitemid 47101060)
67. Schramek, H. (2002). MAP kinases: from intracellular signals to physiology and disease. News Physiol. Sci. 17, 62-67.
68. Shanwell, A., Falker, C., and Gullikkson, H. (2003). Storage of platelets in additive solutions: the effects of magnesium and potassium on the release of RANTES, beta-thromboglobulin, platelet factor 4 and interleukin-7, during storage. Vox Sang. 85, 206-212. (Pubitemid 37247804)
69. Shehata, N., Tinmouth, A., Naglie, G. et al. (2009). ABO-identical versus nonidentical platelet transfusion: a systematic review. Transfusion 49, 2442-2453.
70. Shen, E. C., Chou T. C., Gau, C. H., et al. (2006). Releasing growth factors from activated human platelets after chitosan stimulation: a possible bio-material for platelet-rich plasma preparation. Clin. Oral Implants Res. 17, 572-578.
71. Spreafico, A., Chellini, F., Frediani, B., et al. (2009). Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes. J. Cell. Biochem. 108, 1153-1165.
72. Stock, U. A. and Vacanti, J. P. (2001). Tissue engineering: current state and prospects. Annu. Rev. Med. 52, 443-451. (Pubitemid 32195334)
73. Stroncek, D. F. and Rebulla, P. (2007). Platelet transfusions. Lancet 370, 427-438. (Pubitemid 47189674)
74. Taupin, P. (2006). Derivation of embryonic stem cells for cellular therapy: challenges and new strategies. Med. Sci. Monit. 12, RA75-78.
75. Taupin, P. (2007). Stem cells engineering for cell-based therapy. J. Neural. Eng. 4, R59-63.
76. Treisman, R. (1996). Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol. 8, 205-215.
77. van der Valk, J., Mellor, D., Brands, R., et al. (2004). The humane collection of fetal bovine serum and possibilities for serum-free cell and tissue culture. Toxicol. In Vitro 18, 1-12. (Pubitemid 37431045)
78. van der Valk, J., Brunner, D., De Smet, K., et al. (2010). Optimization of chemically defined cell culture media - replacing fetal bovine serum in mammalian in vitro methods. Toxicol. In Vitro 24, 1053-1063.
79. Weibrich, G., Kleis, W. K., Hafner, G., and Hitzler, W. E. (2002). Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J. Craniomaxillofac. Surg. 30, 97-102. (Pubitemid 34846492)
80. Zimmermann, R., Arnold, D., Strasser, E., et al. (2003). Sample preparation technique and white cell content influence the detectable levels of growth factors in platelet concentrates. Vox Sang. 85, 283-289. (Pubitemid 37522602)